Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 23.40 is 292% above its 5-year average of 5.97, near the high end of its 5-year range (1.65–23.40).
As of the fiscal period ended Tuesday, June 30, 2026. 80.42% above its 12-month average of 12.97.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 23.40.
QUICK RATIO (ACID-TEST)
23.40
QUICK RATIO (ACID-TEST) AVG TTM
12.97
QUICK RATIO (ACID-TEST) AVG 3Y
5.09
QUICK RATIO (ACID-TEST) AVG 5Y
5.97
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+80.42%
CURRENT VS 3Y AVG
+359.64%
CURRENT VS 5Y AVG
+291.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+598.40%
vs the sector median at left
Equillium, Inc.
Market Cap
$91.05M
Quick Ratio (Acid-Test)
23.40
TTM Avg
12.97
3Y Avg
5.09
5Y Avg
5.97
Market Cap
$91.15M
Quick Ratio (Acid-Test)
1.00
TTM Avg
1.24
3Y Avg
1.67
5Y Avg
2.90
Market Cap
$90.37M
Quick Ratio (Acid-Test)
3.47
TTM Avg
4.19
3Y Avg
5.60
5Y Avg
16.48
Market Cap
$89.95M
Quick Ratio (Acid-Test)
27.26
TTM Avg
12.68
3Y Avg
13.62
5Y Avg
17.71
Market Cap
$88.66M
Quick Ratio (Acid-Test)
2.71
TTM Avg
1.86
3Y Avg
1.80
5Y Avg
2.82
Market Cap
$87.62M
Quick Ratio (Acid-Test)
4.50
TTM Avg
8.19
3Y Avg
12.95
5Y Avg
15.06
Market Cap
$95.93M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$96.06M
Quick Ratio (Acid-Test)
7.92
TTM Avg
8.53
3Y Avg
9.72
5Y Avg
13.43
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Equillium, Inc. (EQ) | $91.05M | 23.40 | 12.97 | 5.09 | 5.97 |
| electroCore, Inc. (ECOR)vs › | $91.15M | 1.00 | 1.24 | 1.67 | 2.90 |
| Biomea Fusion, Inc. (BMEA)vs › | $90.37M | 3.47 | 4.19 | 5.60 | 16.48 |
| Rallybio Corporation (RLYB)vs › | $89.95M | 27.26 | 12.68 | 13.62 | 17.71 |
| ImmuCell Corporation (ICCC)vs › | $88.66M | 2.71 | 1.86 | 1.80 | 2.82 |
| CareCloud, Inc. (CCLD)vs › | $88.60M | 1.01 | 1.14 | 1.20 | 1.25 |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $87.62M | 4.50 | 8.19 | 12.95 | 15.06 |
| Conexeu Sciences Inc. (CNXU)vs › | $95.93M | N/A | N/A | N/A | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $96.06M | 7.92 | 8.53 | 9.72 | 13.43 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $96.58M | 1.12 | 0.72 | 0.57 | 0.57 |
Quick Ratio
23.40
Excludes inventory
Current Ratio
23.40
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 23.40 |
| 2026-03-31 | 18.62 |
| 2025-12-31 | 10.32 |
| 2025-09-30 | 10.85 |
| 2025-06-30 | 1.65 |
| 2025-03-31 | 2.70 |
| 2024-12-31 | 3.93 |
| 2024-09-30 | 3.04 |
| 2024-06-30 | 2.08 |
| 2024-03-31 | 1.91 |
| 2023-12-31 | 1.79 |
| 2023-09-30 | 1.91 |
| 2023-06-30 | 2.27 |
| 2023-03-31 | 2.19 |
| 2022-12-31 | 2.40 |
| 2022-09-30 | 3.13 |
| 2022-06-30 | 3.98 |
| 2022-03-31 | 5.50 |
| 2021-12-31 | 9.35 |
| 2021-09-30 | 11.85 |
| 2021-06-30 | 19.99 |
| 2021-03-31 | 14.37 |
| 2020-12-31 | 11.76 |
| 2020-09-30 | 17.91 |
| 2020-06-30 | 13.04 |
| 2020-03-31 | 13.43 |
| 2019-12-31 | 14.30 |
| 2019-09-30 | 14.72 |
| 2019-06-30 | 15.78 |
| 2019-03-31 | 20.52 |
| 2018-12-31 | 33.12 |
| 2018-09-30 | 1.89 |
| 2018-06-30 | 11.55 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.00 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
